Aequus Pharmaceuticals Inc. (TSXV:AQS) announced a non-brokered private placement of 1,000,000 units at a price of CAD 0.30 per unit for gross proceeds of CAD 300,000 to a single investor on January 11, 2018. Each unit will consist of one common share of the company and one non-transferrable common share purchase warrant. Each warrant shall entitle the holder thereof to purchase one common share at an exercise price of CAD 0.50 for a period of twenty-four months following the closing date. The warrants will include an acceleration provision, exercisable at the company’s option; if the company's daily volume weighted average share price is greater than CAD 0.85 for 10 consecutive trading days. The securities issued under the transaction will be subject to a four month hold period. The transaction is expected to close on or about the week of January 22, 2018. Completion of the transaction is subject to a number of conditions, including the execution of definitive documentation and receipt of any required regulatory approvals, including receipt of the approval of the TSX Venture Exchange for the listing of the common shares issuable on closing and issuable upon the exercise of the Warrants.